daniela juri

Lead all aspects of business development and sales. Provided language services to organizations in the United States and internationally. Hired and managed contract employees and occasionally provided translation and interpretation services to select high-profile clients.

Developed relationships with universities worldwide and lead all aspects of operation for the company. Devised and executed strategies to align program offerings with clients' needs. Familiar with university administrative and bidding processes. Researched and analyzed RFPs and developed and presented study abroad program proposals. Organized and directed program departure presentations and briefings. Supervised account managers and international program coordinators.

Developed international brand and commercialization strategies. Responsible for strategic sales and marketing plan for international markets for the company inclusive of sales force expansion, product localization and integration, distributorship and laboratory partnership opportunities. Launched sales and marketing initiatives globally for the company’s PCR and next generation genetic tests. Responsible for building relationships with laboratories, diagnostic companies, PBMs, hospitals, clinics, and foreign governments. Drove Key Opinion Leader (KOL) relationships and developed international speakers. In charge of international product registrations, international account managers and consultants.

* San Diego State University, San Diego, California (Spanish) * Palomar College, San Marcos, California (German, Spanish) * San Diego Miramar College, San Diego, California (Spanish)

Responsible for developing commercialization strategies for Latin America inclusive of strategic sales, education and marketing plans on a country per country basis. Select, develop and coordinate bilingual Latin America task force comprised of physicians, biomedical engineers, genetic counselors and regional sales managers. Develop key strategic partnerships with institutions, distributors, laboratories, patient advocacy groups, not-for-profit organizations, payors and governments. Identify and develop KOLs in the areas of oncology, cardiology, neurology and pediatrics. Drive revenue pull through by coordinating and collaborating with cross-functional teams.

Guardant Health develops breakthrough diagnostic technologies to improve cancer management. With Guardant360, we offer real-time, biopsy-free tumor sequencing that tracks tumor genomics in real-time and identifies associated treatment options. The recent introduction of groundbreaking analytical tools, including our Tumor Response Map and a mobile-enabled physician portal, further advance Guardant Health's momentum. Guardant Health is backed by Sequoia Capital, Khosla Ventures, Lightspeed Ventures, and Formation 8, and is led by a seasoned management team of thought leaders and successful serial entrepreneurs in next generation sequencing and rare cell diagnostics. They are advised by an oncologist-led medical steering committee from leading cancer centers.